نتائج البحث - "Alexandre Corjon"

المساهمون: Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie (BECCOH), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Saclay, Infection et inflammation (2I), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), HAL UVSQ, Équipe, Hôpital Ambroise Paré [AP-HP], Hôpital Raymond Poincaré [AP-HP]

المصدر: Cancers
Cancers, Vol 13, Iss 97, p 97 (2021)
Cancers, MDPI, 2021, 13 (1), pp.1-12. ⟨10.3390/cancers13010097⟩
Cancers, MDPI, 2021, 13 (1), pp.97. ⟨10.3390/cancers13010097⟩
Volume 13
Issue 1

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Fibroblast growth factor, immune checkpoint inhibitor, [SDV.CAN]Life Sciences [q-bio]/Cancer, Pembrolizumab, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, lcsh:RC254-282, Article, resistance, 03 medical and health sciences, 0302 clinical medicine, Immune system, [SDV.CAN] Life Sciences [q-bio]/Cancer, Internal medicine, Medicine, Multiplex, 030212 general & internal medicine, Adverse effect, Lung cancer, non-small cell lung cancer, plasma, interleukine-12, business.industry, toxicity, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 3. Good health, respiratory tract diseases, hepatocyte growth factor, 030220 oncology & carcinogenesis, Toxicity, Biomarker (medicine), [SDV.MHEP.PSR] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, biomarker, Nivolumab, [SDV.IMM.IMM] Life Sciences [q-bio]/Immunology/Immunotherapy, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21f6ae4504867a2fb595613ee61eac01Test
https://pubmed.ncbi.nlm.nih.gov/33396187Test

4

Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression

المؤلفون: Adrien Costantini, Paul Takam Kamga, Thierry Chinet, Jean-François Emile, Etienne Giroux Leprieur, Simon Garinet, Sylvie Labrune, Alexandre Corjon, Zofia Hélias-Rodzewicz, Coraline Dumenil, Catherine Julie, Violaine Giraud, Jennifer Dumoulin

المساهمون: Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Hôpital Ambroise Paré [AP-HP], Service de pathologie [CHU Ambroise Paré], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Ambroise Paré [AP-HP], Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer, BMJ Publishing Group 2020, 8 (1), ⟨10.1136/jitc-2020-000527⟩

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Lung Neoplasms, Time Factors, DNA Mutational Analysis, Programmed Cell Death 1 Receptor, Pembrolizumab, B7-H1 Antigen, Circulating Tumor DNA, 0302 clinical medicine, biomarkers, tumor, Carcinoma, Non-Small-Cell Lung, Immunology and Allergy, Immune Checkpoint Inhibitors, Lung, Exome sequencing, RC254-282, Clinical/Translational Cancer Immunotherapy, Aged, 80 and over, biology, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Progression-Free Survival, 3. Good health, Nivolumab, 030220 oncology & carcinogenesis, Disease Progression, Molecular Medicine, Adenocarcinoma, Female, Microsatellite Instability, Drug Monitoring, Adult, tumor, medicine.medical_specialty, DNA Copy Number Variations, Immunology, [SDV.CAN]Life Sciences [q-bio]/Cancer, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, Immune system, Internal medicine, Exome Sequencing, medicine, Humans, PTEN, Lung cancer, Aged, Neoplasm Staging, Retrospective Studies, Pharmacology, business.industry, biomarkers, medicine.disease, 030104 developmental biology, Drug Resistance, Neoplasm, Tumor progression, Mutation, biology.protein, business